These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
386 related items for PubMed ID: 16214830
1. Efficacy of ivabradine, a new selective I(f) inhibitor, compared with atenolol in patients with chronic stable angina. Tardif JC, Ford I, Tendera M, Bourassa MG, Fox K, INITIATIVE Investigators. Eur Heart J; 2005 Dec; 26(23):2529-36. PubMed ID: 16214830 [Abstract] [Full Text] [Related]
2. Efficacy of the I(f) current inhibitor ivabradine in patients with chronic stable angina receiving beta-blocker therapy: a 4-month, randomized, placebo-controlled trial. Tardif JC, Ponikowski P, Kahan T, ASSOCIATE Study Investigators. Eur Heart J; 2009 Mar; 30(5):540-8. PubMed ID: 19136486 [Abstract] [Full Text] [Related]
3. Heart rate slowing versus other pharmacological antianginal strategies. Diaz A, Tardif JC. Adv Cardiol; 2006 Mar; 43():65-78. PubMed ID: 16936473 [Abstract] [Full Text] [Related]
4. Angina: Ivabradine for treatment of stable angina pectoris. de Silva R, Fox KM. Nat Rev Cardiol; 2009 May; 6(5):329-30. PubMed ID: 19377492 [Abstract] [Full Text] [Related]
5. Effects of ranolazine with atenolol, amlodipine, or diltiazem on exercise tolerance and angina frequency in patients with severe chronic angina: a randomized controlled trial. Chaitman BR, Pepine CJ, Parker JO, Skopal J, Chumakova G, Kuch J, Wang W, Skettino SL, Wolff AA, Combination Assessment of Ranolazine In Stable Angina (CARISA) Investigators. JAMA; 2004 Jan 21; 291(3):309-16. PubMed ID: 14734593 [Abstract] [Full Text] [Related]
6. Antianginal and antiischemic effects of ivabradine, an I(f) inhibitor, in stable angina: a randomized, double-blind, multicentered, placebo-controlled trial. Borer JS, Fox K, Jaillon P, Lerebours G, Ivabradine Investigators Group. Circulation; 2003 Feb 18; 107(6):817-23. PubMed ID: 12591750 [Abstract] [Full Text] [Related]
10. Effects of ivabradine in patients with stable angina receiving β-blockers according to baseline heart rate: an analysis of the ASSOCIATE study. Tardif JC, Ponikowski P, Kahan T, ASSOCIATE Investigators. Int J Cardiol; 2013 Sep 30; 168(2):789-94. PubMed ID: 23138014 [Abstract] [Full Text] [Related]
11. The efficacy and safety of ivabradine hydrochloride versus atenolol in Chinese patients with chronic stable angina pectoris. Li Y, Jing L, Li Y, Jiang J, Wang Z, Wei J, Li X, Wang L, Xia H, Li T, Liu S, Xing B, Yang Z, Lu Q, Jiang R, Xie P, Shou X, Wang X, Jia Y. Pharmacoepidemiol Drug Saf; 2014 Nov 30; 23(11):1183-91. PubMed ID: 24757084 [Abstract] [Full Text] [Related]
13. Ivabradine: a selective If current inhibitor in the treatment of stable angina. Andrikopoulos G, Dasopoulou C, Sakellariou D, Tzeis S, Koulouris S, Kranidis A, Kappos K, Manolis AS. Recent Pat Cardiovasc Drug Discov; 2006 Nov 30; 1(3):277-82. PubMed ID: 18221092 [Abstract] [Full Text] [Related]
16. [Comparative efficacy of ivabradine and atenolol in correction of clinical and functional parameters in patients with stable effort angina]. Tatarchenko IP, Pozdniakova NV, Biriuchenko MV. Kardiologiia; 2008 Nov 30; 48(5):60-1. PubMed ID: 18537806 [No Abstract] [Full Text] [Related]
18. Ivabradine in combination with beta-blocker therapy for the treatment of stable angina pectoris in every day clinical practice. Koester R, Kaehler J, Ebelt H, Soeffker G, Werdan K, Meinertz T. Clin Res Cardiol; 2010 Oct 30; 99(10):665-72. PubMed ID: 20454968 [Abstract] [Full Text] [Related]
19. [Ivabradine (Procoralan)]. Lancellotti P. Rev Med Liege; 2008 Apr 30; 63(4):220-4. PubMed ID: 18575078 [Abstract] [Full Text] [Related]